Schonfeld Strategic Advisors’s LifeMD LFMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-28,549
Closed -$389K 2404
2025
Q2
$389K Buy
28,549
+12,949
+83% +$122K ﹤0.01% 1620
2025
Q1
$84.9K Buy
+15,600
New +$88.5K ﹤0.01% 2034
2024
Q2
Sell
-60,749
Closed -$624K 2376
2024
Q1
$624K Buy
60,749
+49,306
+431% +$364K ﹤0.01% 1399
2023
Q4
$94.9K Buy
+11,443
New +$82.3K ﹤0.01% 1628
2021
Q2
Sell
-33,664
Closed -$532K 2134
2021
Q1
$532K Buy
+33,664
New +$606K 0.01% 1116

Other funds holding LFMD

Schonfeld Strategic Advisors's LFMD Position: Q3 2025 in Review

Schonfeld Strategic Advisors sold out of LifeMD (LFMD) in Q3 2025, closing a stake of 28,549 shares — an estimated $389K sold.

Schonfeld Strategic Advisors first reported a position in LFMD in Q1 2021 and held it in 5 quarters. The position peaked at $624K in Q1 2024. 114 funds tracked by Wall St. Rank hold LFMD as of Q3 2025.

  • Schonfeld Strategic Advisors reported no remaining LifeMD position as of Q3 2025 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 28,549 LifeMD shares in Q3 2025, an estimated $389K.
  • Schonfeld Strategic Advisors first reported a position in LifeMD in Q1 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's LifeMD position peaked at $624K in Q1 2024.
  • 114 funds tracked by Wall St. Rank held LifeMD as of Q3 2025.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.